JAMES BURROW: Open Payments
NPI 1659819688 · LEXINGTON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$571 in 26 payments from 11 companies in 2025. Trend: 2023 $44 · 2024 $187 · 2025 $571
Food & beverage: $571
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $138 |
| Novo Nordisk Inc | 5 | $102 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $75 |
| Verona Pharma, Inc. | 2 | $63 |
| Exact Sciences Corporation | 2 | $50 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $45 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| PFIZER INC. | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 2 | $21 |
| Lilly USA, LLC | 1 | $17 |
Products named: JARDIANCE, AIRSUPRA, Ohtuvayre, BREZTRI, Rybelsus, The Cologuard Plus Collection Kit, Ozempic, CAPLYTA.
Industry payments across TN — which companies pay providers there.
